Table 1. Clinicopathological characteristics and E-cadherin expression in pancreatic cancer patients stratified by RAB5 expression.
Factors | RAB5expression | ||
---|---|---|---|
Low (n=50) | High (n=61) | p-value | |
Age | 0.902 | ||
<70 | 26 | 31 | |
≧70 | 24 | 30 | |
Gender | 0.812 | ||
male | 29 | 34 | |
female | 21 | 27 | |
Histology type | 0.107 | ||
well | 9 | 6 | |
mod,por | 30 | 50 | |
Tumor size stage | 0.088 | ||
TS1,2 | 34 | 50 | |
TS3,4 | 16 | 11 | |
Tumor stage | 0.505 | ||
T1-3 | 31 | 34 | |
T4 | 19 | 27 | |
Lymph node metastasis | 0.135 | ||
N0 | 17 | 13 | |
N1 | 33 | 48 | |
Lymphatic invasion | 0.012* | ||
ly0 | 5 | 0 | |
ly1,2,3 | 45 | 60 | |
Venous invasion | 0.019* | ||
v0 | 8 | 2 | |
v1,2,3 | 42 | 58 | |
Peri-neural invasion | 0.060 | ||
ne0,1 | 19 | 13 | |
ne2,3 | 31 | 47 | |
Infiltration | 0.068 | ||
α | 2 | 0 | |
β | 37 | 37 | |
γ | 11 | 23 | |
pStage(UICC) | 0.088 | ||
I,IIA | 17 | 12 | |
IIB,III,IV | 33 | 49 | |
Recurrence | 0.805 | ||
absent | 35 | 44 | |
present | 15 | 17 | |
E-cadherin expression | 0.010* | ||
high | 35 | 28 | |
low | 15 | 33 |
*p<0.05.
well: well differentiated, mod: moderately differentiated, por: poorly differentiated.